Grantham, Mayo, Van Otterloo & Co (GMO)’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-4,260
| Closed | -$261K | – | 541 |
|
2023
Q4 | $261K | Sell |
4,260
-2,574
| -38% | -$158K | ﹤0.01% | 453 |
|
2023
Q3 | $391K | Sell |
6,834
-52,959
| -89% | -$3.03M | ﹤0.01% | 511 |
|
2023
Q2 | $3.55M | Sell |
59,793
-10,285
| -15% | -$611K | 0.02% | 377 |
|
2023
Q1 | $4.39M | Sell |
70,078
-23,700
| -25% | -$1.48M | 0.02% | 336 |
|
2022
Q4 | $5.87M | Sell |
93,778
-23,700
| -20% | -$1.48M | 0.03% | 311 |
|
2022
Q3 | $5.85M | Sell |
117,478
-113,700
| -49% | -$5.67M | 0.03% | 310 |
|
2022
Q2 | $13.6M | Buy |
231,178
+3,800
| +2% | +$223K | 0.07% | 217 |
|
2022
Q1 | $12M | Sell |
227,378
-34,154
| -13% | -$1.81M | 0.06% | 232 |
|
2021
Q4 | $15.9M | Sell |
261,532
-1,956
| -0.7% | -$119K | 0.08% | 197 |
|
2021
Q3 | $14.8M | Buy |
263,488
+4,400
| +2% | +$247K | 0.07% | 204 |
|
2021
Q2 | $13.5M | Buy |
259,088
+13,152
| +5% | +$685K | 0.07% | 207 |
|
2021
Q1 | $10.8M | Buy |
245,936
+16,736
| +7% | +$738K | 0.06% | 229 |
|
2020
Q4 | $7.99M | Sell |
229,200
-237,400
| -51% | -$8.28M | 0.05% | 220 |
|
2020
Q3 | $17M | Buy |
466,600
+27,574
| +6% | +$1M | 0.12% | 101 |
|
2020
Q2 | $16.5M | Buy |
439,026
+4,526
| +1% | +$170K | 0.12% | 99 |
|
2020
Q1 | $15.9M | Buy |
434,500
+125,200
| +40% | +$4.59M | 0.13% | 101 |
|
2019
Q4 | $12.5M | Buy |
309,300
+126,500
| +69% | +$5.12M | 0.08% | 162 |
|
2019
Q3 | $6.34M | Buy |
182,800
+96,100
| +111% | +$3.33M | 0.04% | 262 |
|
2019
Q2 | $2.75M | Buy |
86,700
+48,500
| +127% | +$1.54M | 0.02% | 398 |
|
2019
Q1 | $1.14M | Buy |
+38,200
| New | +$1.14M | 0.01% | 467 |
|